BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeo D, Bastian A, Strauss H, Saxena P, Grimison P, Rasko JEJ. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. Int J Mol Sci 2022;23:1671. [PMID: 35163592 DOI: 10.3390/ijms23031671] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nitschke C, Markmann B, Tölle M, Kropidlowski J, Belloum Y, Goetz MR, Schlüter H, Kwiatkowski M, Sinn M, Izbicki J, Pantel K, Güngör C, Uzunoglu FG, Wikman H. Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients. Cancers (Basel) 2022;14:4405. [PMID: 36139565 DOI: 10.3390/cancers14184405] [Reference Citation Analysis]
2 Tonini V, Zanni M. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe. World J Gastroenterol 2022; 28(31): 4235-4248 [DOI: 10.3748/wjg.v28.i31.4235] [Reference Citation Analysis]
3 Götze J, Nitschke C, Uzunoglu FG, Pantel K, Sinn M, Wikman H. Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications. Front Cell Dev Biol 2022;10:918795. [PMID: 35712663 DOI: 10.3389/fcell.2022.918795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]